- Home
- LPSN vs PLRX Comparison
LPSN vs PLRX Comparison
Compare LPSN & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPSN | PLRX |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.5M | 93.3M |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LPSN | PLRX |
|---|---|---|
| Price | $4.09 | $1.24 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 11 |
| Target Price | N/A | ★ $3.79 |
| AVG Volume (30 Days) | 202.7K | ★ 1.9M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $257,660,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.91 | $1.10 |
| 52 Week High | $31.20 | $13.71 |
Technical Indicators
Market Signals| Indicator | LPSN | PLRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.24 | 39.91 |
| Support Level | $3.91 | $1.20 |
| Resistance Level | $4.18 | $1.27 |
| Average True Range (ATR) | 0.26 | 0.06 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 11.08 | 29.03 |
Price Performance
Historical ComparisonAbout LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.